France Aesthetic Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers France Aesthetic Medicine Market Share & Trends and it is Segmented by Product (Botulinum Toxin, Dermal Filler, Chemical Peel, Microdermabrasion, and Other Products) and End User (Aesthetic Clinics, Hospitals, and Other End Users). The market size and forecasts are provided in terms of value (in USD million) for all the above segments.

France Aesthetic Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

France Aesthetic Medicine Market Size

France Aesthetic Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 560.89 Million
Market Size (2030) USD 930.75 Million
CAGR (2025 - 2030) 10.66 %

Major Players

France Aesthetic Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of France Aesthetic Medicine Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

France Aesthetic Medicine Market Analysis

The France Aesthetic Medicine Market size is estimated at USD 560.89 million in 2025, and is expected to reach USD 930.75 million by 2030, at a CAGR of 10.66% during the forecast period (2025-2030).

  • Due to the high infectivity of the SARS-CoV-2 virus and lockdown regulations by the government, the COVID-19 pandemic led to the cancellation or postponement of cosmetic treatment treatments, which had an effect on the market for aesthetic medicine in France.
  • For instance, according to an article published by the American Society of Plastic Surgeons (ASPS) in February 2021, owing to the strict lockdown imposed in the country, the COVID-19 pandemic significantly changed how plastic surgeons practiced throughout the world, including France. Disruptions in the supply chain posed a significant challenge as the demand decreased due to lower customer purchasing power and willingness to buy.
  • According to the French Beauty Federation (FEBEA), the French cosmetic industry saw a 10% decline in revenue during the first half of 2020. The consumers' focus shifted from beauty products to hygiene, with hygiene sales increasing by 50% while beauty product sales decreased by 25%. Cosmetic exports in France fell by 14%, while investments decreased by 12%, which are lower than the national averages of 18% and 16%, respectively. Hence, COVID-19 is expected to impact the studied market significantly.
  • The aesthetic medicine market in France is expected to grow during the forecast period owing to increasing awareness about cosmetic procedures and the adoption of non- and minimally-invasive aesthetic procedures.
  • For instance, according to the 2020 report of the International Society of Aesthetic Plastic Surgery (ISAPS), France was one of the top fifteen countries in the world with the highest number of plastic surgeons in the country performing various cosmetic procedures in the country. Additionally, France is becoming a popular destination for cosmetic surgery, which is anticipated to benefit the aesthetic medicine market.
  • For instance, according to an article published in September 2021 titled "What are the Most Performed Cosmetic Surgery Operations in France?" France is one of the major destinations where most buttock enlargement procedures are performed. Also, per the same source, in France, each year, 479 cosmetic surgery procedures are performed for 100,000 people compared to other countries (166 interventions in Japan, 254 in the United Kingdom, and 69 in India). Thus, an increase in cosmetic procedures in France is expected to drive the market in the forecast period.
  • However, stringent safety regulations for aesthetic procedures and related adverse effects are expected to restrain France's aesthetic medicine market growth during the forecast period.

France Aesthetic Medicine Industry Overview

The France aesthetic medicine market is moderate due to the presence of companies operating globally as well as regionally.

The competitive landscape includes an analysis of a few international as well as local companies which hold significant market shares and are well known including AbbVie Inc. (Allergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Sinclair Pharma PLC, and Johnson & Johnson, among others.

France Aesthetic Medicine Market Leaders

  1. AbbVie Inc. (AlLergan Plc)

  2. Bioxis Pharmaceuticals

  3. Dermaceutic Laboratoire

  4. Ipsen Pharma

  5. Johnson & Johnson

  6. *Disclaimer: Major Players sorted in no particular order
France Aesthetic Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

France Aesthetic Medicine Market News

  • January 2022: The European Union's (EU's) Heads of Medicines Agencies (HMA) issued a positive opinion on the approval of Hugel's Letybo, a product containing botulinum toxin (BTX) for the treatment of wrinkles on the forehead.
  • June 2021: Galderma announced that Alluzience® completed its European decentralized procedure resulting in a positive decision for the first ready-to-use neuromodulator, a wrinkle relaxing injection, in Europe.

France Aesthetic Medicine Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Awareness and Adoption of Non- and Minimally-Invasive Aesthetic Procedures
    • 4.2.2 Availability of Technologically Advanced & User-friendly Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Safety Regulations for Aesthetic Procedures
    • 4.3.2 Risk of Side Effects
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product
    • 5.1.1 Botulinum Toxin
    • 5.1.2 Dermal Filler
    • 5.1.2.1 Absorbable Dermal Filler
    • 5.1.2.2 Non-absorbable Dermal Filler
    • 5.1.3 Chemical Peel
    • 5.1.4 Microdermabrasion
    • 5.1.5 Other Products
  • 5.2 By End User
    • 5.2.1 Aesthetic Clinics
    • 5.2.2 Hospitals
    • 5.2.3 Other End Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc. (AlLergan Plc)
    • 6.1.2 Bioxis Pharmaceuticals
    • 6.1.3 Dermaceutic Laboratoire
    • 6.1.4 Ipsen Pharma
    • 6.1.5 Sinclair Pharma PLC
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Galderma(Nestle Skin Health)
    • 6.1.8 Merz Pharma GmbH & Co. KGaA
    • 6.1.9 Laboratoires Filorga
    • 6.1.10 Teoxane Laboratories
    • 6.1.11 Laboratories Vivacy
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

France Aesthetic Medicine Industry Segmentation

Aesthetic medicine is defined as the specialties that focus on enhancing cosmetic appearance through the treatment of aging, infectious, or diseased skin conditions. 

The France aesthetic medicine market is segmented by product (botulinum toxin, dermal filler (absorbable dermal filler and non-absorbable dermal filler), chemical peel, microdermabrasion, and other products) and end-user (aesthetic clinics, hospitals, and other end users). The market report also covers the estimated market sizes and trends for France. The report offers the value (in USD million) for the above segments.

By Product Botulinum Toxin
Dermal Filler Absorbable Dermal Filler
Non-absorbable Dermal Filler
Chemical Peel
Microdermabrasion
Other Products
By End User Aesthetic Clinics
Hospitals
Other End Users
Need A Different Region or Segment?
Customize Now

France Aesthetic Medicine Market Research FAQs

How big is the France Aesthetic Medicine Market?

The France Aesthetic Medicine Market size is expected to reach USD 560.89 million in 2025 and grow at a CAGR of 10.66% to reach USD 930.75 million by 2030.

What is the current France Aesthetic Medicine Market size?

In 2025, the France Aesthetic Medicine Market size is expected to reach USD 560.89 million.

Who are the key players in France Aesthetic Medicine Market?

AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma and Johnson & Johnson are the major companies operating in the France Aesthetic Medicine Market.

What years does this France Aesthetic Medicine Market cover, and what was the market size in 2024?

In 2024, the France Aesthetic Medicine Market size was estimated at USD 501.10 million. The report covers the France Aesthetic Medicine Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the France Aesthetic Medicine Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

France Aesthetic Industry Report

Statistics for the 2025 France Aesthetic Medicine market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Aesthetic Medicine analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

France Aesthetic Market Report Snapshots